A special meeting of the shareholders of Rochester Medical Corporation (the Company) was held on November 13, 2013 (the Special Meeting). There were 12,359,643 shares of common stock entitled to vote at the Special Meeting; 8,411,775 shares were represented at the meeting in person or by proxy. The Companys shareholders voted on three matters at the Special Meeting, each of which was approved pursuant to the following final voting results from the Special Meeting:

1. A proposal to approve the Agreement and Plan of Merger, dated as of September 3, 2013, by and among C. R. Bard, Inc. (Bard), Starnorth Acquisition Corp. (Merger Sub) and the Company (the Merger Agreement), pursuant to which Merger Sub would merge with and into the Company, with the Company as the surviving corporation (Merger) and a wholly owned subsidiary of Bard.

For

Against

Abstain

Broker Non-Vote

8,184,372

179,156

12,054

36,193

2. A non-binding, advisory proposal to approve the compensation that may become payable to the Companys named executive officers in connection with the completion of the Merger.

For

Against

Abstain

Broker Non-Vote

7,929,355

275,435

170,792

36,193

3. A proposal by the Companys board of directors to adjourn the Special Meeting, if necessary, to solicit additional proxies for the approval of the Merger Agreement if there are not sufficient votes at the time of the special meeting in favor of approval of the merger agreement.

For

Against

Abstain

Broker Non-Vote

7,815,052

566,071

30,652

0

Adjournment and postponement of the Special Meeting was not necessary or appropriate because there were sufficient votes at the time of the Special Meeting to approve the Merger Agreement.

Item 8.01. Other Events

The closing of the Merger remains subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement. It is currently expected that the closing of the Merger will take place on or about November 14, 2013, assuming satisfaction or waiver of all such conditions to closing.

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Site Links

Based on public records. Inadvertent errors are possible. Getfilings.com does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC.